Jiangsu Hengrui Pharmaceuticals Co Ltd Class A 600276
About Quantitative Ratings
Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies with quantitative ratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating.
Is it the right time to buy, sell, or hold?
Start a free trial of Morningstar Investor to unlock exclusive ratings and continuous analyst coverage to help you decide if 600276 is a good fit for your portfolio.
News
Trading Information
- Previous Close Price
- CNY 46.90
- Day Range
- CNY 46.19–47.05
- 52-Week Range
- CNY 35.51–50.50
- Bid/Ask
- CNY 46.47 / CNY 46.48
- Market Cap
- CNY 296.50 Bil
- Volume/Avg
- 15.6 Mil / 27.9 Mil
Key Statistics
- Price/Earnings (Normalized)
- 63.86
- Price/Sales
- 12.59
- Dividend Yield (Trailing)
- 0.34%
- Dividend Yield (Forward)
- 0.34%
- Total Yield
- 0.34%
Company Profile
Jiangsu Hengrui Pharmaceuticals Co Ltd is engaged in the field of cancer treatment drugs, surgical medicines, endocrine therapy drugs, cardiovascular drugs and anti-infection medications. It specializes in the research and development of new medicines in areas of antineoplastics, endocrine system, cardiovascular, and the immune system.
- Sector
- Healthcare
- Industry
- Drug Manufacturers - General
- Stock Style Box
- Large Growth
- Total Number of Employees
- 19,611
- Website
- http://www.hrs.com.cn
Comparables
Valuation
Metric
|
600276
|
600594
|
300194
|
---|---|---|---|
Price/Earnings (Normalized) | 63.86 | — | 17.46 |
Price/Book Value | 7.07 | 1.12 | 1.20 |
Price/Sales | 12.59 | 1.24 | 1.90 |
Price/Cash Flow | 33.82 | 8.10 | 9.54 |
Price/Earnings
600276
600594
300194
Financial Strength
Metric
|
600276
|
600594
|
300194
|
---|---|---|---|
Quick Ratio | — | 1.25 | 1.18 |
Current Ratio | — | 1.90 | 1.77 |
Interest Coverage | — | 1.12 | 10.96 |
Quick Ratio
600276
600594
300194
Profitability
Metric
|
600276
|
600594
|
300194
|
---|---|---|---|
Return on Assets (Normalized) | 10.04% | −0.72% | 0.94% |
Return on Equity (Normalized) | 10.92% | −1.13% | 1.40% |
Return on Invested Capital (Normalized) | 9.87% | −0.39% | 1.12% |
Return on Assets
600276
600594
300194
Drug Manufacturers - General Industry Comparables
Ticker
|
Name
|
Morningstar Rating for Stocks
|
Capital Allocation
|
Economic Moat
|
Market Cap
|
---|---|---|---|---|---|
LLY
| Eli Lilly and Co | Dpmyvfgsd | Wdcxb | $733.3 Bil | |
JNJ
| Johnson & Johnson | Pzpzsfmp | Rskt | $360.8 Bil | |
MRK
| Merck & Co Inc | Bccbqvstg | Nxt | $329.8 Bil | |
ABBV
| AbbVie Inc | Mdckykf | Pzrr | $283.3 Bil | |
AZN
| AstraZeneca PLC ADR | Ygrhjmrs | Jslpk | $237.7 Bil | |
NVS
| Novartis AG ADR | Nqcgpgpd | Dtpsv | $203.4 Bil | |
RHHBY
| Roche Holding AG ADR | Kvrszhrpm | Ldgp | $197.6 Bil | |
AMGN
| Amgen Inc | Vdyypzgxhn | Psx | $166.4 Bil | |
PFE
| Pfizer Inc | Lnddsqv | Qnpz | $159.7 Bil | |
SNY
| Sanofi SA ADR | Qjhjmlnn | Mwss | $125.1 Bil |